A. Trés
Pulmonary and Respiratory Medicine · 2007–2011
A researcher in the Science corpus: 5 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Pulmonary and Respiratory Medicine — 13 citations into it
Whom A. Trés trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- E. Hall (in Pulmonary and Respiratory Medicine)
Papers from A. Trés's perspective
Ordered by how strongly the researchers A. Trés trusts endorse each paper. Same corpus, a different order for every researcher.
- Transport of molecules across tumor vasculature (Cancer Metastasis Review)
- Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. (Biomaterials)
- Nanoparticles in Medicine: Therapeutic Applications and Developments (Clinical pharmacology and therapy)
- Tyrosine kinases as targets for cancer therapy. (New England Journal of Medicine)
- Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study (The Lancet Oncology)
- Computationally Guided Photothermal Tumor Therapy Using Long-Circulating Gold Nanorod Antennas (Cancer Research)
- A clearer vision for in vivo imaging (Nature Biotechnology)
- In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags (Nature Biotechnology)
- Intracranial Thermotherapy using Magnetic Nanoparticles Combined with External Beam Radiotherapy: Results of a Feasibility Study on Patients with Glioblastoma Multiforme (Journal of Neuro-Oncology)
- Nanoparticles in photodynamic therapy: an emerging paradigm. (Advanced Drug Delivery Reviews)
Their papers
- Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes (2007) — 755 citations
- Sequence variants at the TERT- CLPTM1L locus associate with many cancer types (2009) — 638 citations
- Assessment of the Evolution of Cancer Treatment Therapies (2011) — 787 citations
- Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer (2007) — 786 citations
- Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24 (2007) — 910 citations